Unlocking your DNA for personalised medicine
Our next-generation sequencing (WGS/WES) platform delivers complete genomic profiling to identify inherited conditions, cancer predisposition genes, and pharmacogenomic markers that influence how your body responds to medications.
Understand how your unique DNA affects drug metabolism. Our PGx panels cover over 200 medications across cardiology, psychiatry, oncology and pain management helping physicians prescribe the right drug at the right dose the first time.
Targeted gene panels for BRCA1/2, Lynch Syndrome, Familial Hypercholesterolaemia, hereditary cardiomyopathies and over 150 other conditions. Results include genetic counselling consultation and a personalised risk-reduction plan.
Speak to a genetic counsellor and find out which panels are right for you.
Book a Consultation